{
    "nctId": "NCT03220893",
    "briefTitle": "Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue",
    "officialTitle": "Density MATTERS [Molecular Breast Imaging (MBI) And Tomosynthesis To Eliminate the ReServoir]",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Carcinoma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 3023,
    "primaryOutcomeMeasure": "Rate of detection of invasive cancers",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient is a consenting female age 40-75 years\n* Patient is scheduled for routine screening DBT\n* Patient is asymptomatic for breast disease\n* Patient had heterogeneously dense or extremely dense breasts on most recent prior mammography examination (Breast Imaging Reporting and Data System \\[BI-RADS\\] c or d) within 24 months of enrollment\n* Patient is able to participate fully in all aspects of the study (completing study visits and study data collection)\n* Patient understands and signs the study informed consent\n* Patient anticipates being able to return one year after study enrollment to complete the second round of screening\n\nExclusion Criteria:\n\n* Patient is currently pregnant or plans to become pregnant during the course of the study\n* Patient is currently lactating\n* Patient has had a prior MBI\n* Patient has had a prior whole breast ultrasound (WBUS) for screening, with either a hand-held ultrasound probe or automated system, within 12 months prior to study enrollment\n* Patient has had a prior breast MRI\n* Patient has had a prior contrast-enhanced mammogram (contrast enhanced spectral mammography \\[CESM\\] or contrast-enhanced digital mammography \\[CEDM\\])\n* Patient is concurrently participating in any other breast imaging research studies that involve undergoing additional breast imaging tests beyond routine screening with mammography, including but not limited to contrast-enhanced mammography, WBUS, MBI, or contrast-enhanced breast MRI\n* Patient has had a breast biopsy within 3 months prior to study enrollment\n* Patient has had breast surgery within 12 months prior to study enrollment\n* Patient is currently undergoing treatment for breast cancer or planning surgery for a high-risk breast lesion (atypical ductal hyperplasia \\[ADH\\], atypical lobular hyperplasia \\[ALH\\], lobular carcinoma in situ \\[LCIS\\], papilloma, radial scar)\n* Patient is currently taking a chemoprevention agent for breast cancer risk reduction or osteoporosis prevention (tamoxifen, raloxifene, anastrazole, letrozole, exemestane)\n* Patient has a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder study adherence",
    "sex": "FEMALE",
    "minimumAge": "40 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}